Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEBIRI-M1 for Colorectal Cancer Liver Metastases
NCT02015754Phase 2Completed
- Sponsor
- Yale University
- Start
- Feb 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in colorectal cancer (CRC), sponsored by Yale University. Started Feb 2014; status: completed.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02015754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015754.